Cite

HARVARD Citation

    Trédan, O. et al. (2019). Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial. Annals of oncology. pp. 757-765. [Online]. 
  
Back to record